Fundz

Slam Bio Therapeutics reported raising $7.71 Million in an initial SEC Form D filing, from an offering of $20 Million

PRIVATENov 13, 2023$7.7M of $20M raised

Amount Raised

$7.71 Million

$7.71 Million sold, per SEC Form D (first sale Nov 3, 2023)

Round Type

Venture

Thousand OaksBiotechnology

Quick answer

SLAM BioTherapeutics raised $7.71 Million in a funding round, dated November 3, 2023. SLAM BioTherapeutics is based in Thousand Oaks, California, United States.

How much did SLAM BioTherapeutics raise?
SLAM BioTherapeutics raised $7.71 Million in a funding round on November 3, 2023.
What does SLAM BioTherapeutics do?
SLAM Bio is pioneering innovative cancer therapies, developing first-in-class human monoclonal antibodies, bispecifics and ADCs designed to target a family of proteins with high expression in a broad spectrum of blood..
Where is SLAM BioTherapeutics based and how big is it?
SLAM BioTherapeutics is based in Thousand Oaks, California, United States. Fundz records about 11 employees.
Who are the decision-makers at SLAM BioTherapeutics?
Fundz holds 1 contact at SLAM BioTherapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as SLAM BioTherapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Allurion Technologies raised $123K (Pre-Seed) on December 18, 2023.
  • Firefly Bio raised $40M on December 18, 2023.
  • Hemanext raised $5M on December 18, 2023.
  • Sudo Biosciences raised $53M on December 15, 2023.
  • Greenbrook TMS raised $4M (Seed) on December 15, 2023.
  • Ernexa Therapeutics Inc. raised $7.8M on December 15, 2023.

Who to call at SLAM BioTherapeutics, and when

A new round usually means SLAM BioTherapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day SLAM BioTherapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SLAM BioTherapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SLAM BioTherapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SLAM BioTherapeutics

Location

2945 Townsgate Rd., Suite 200

Thousand Oaks, California, United States

About

SLAM Bio is pioneering innovative cancer therapies, developing first-in-class human monoclonal antibodies, bispecifics and ADCs designed to target a family of proteins with high expression in a broad spectrum of blood cancers. The company's therapeutic platform has the potential to transform cancer treatment and significantly improve the lives of patients with life-threatening conditions like AML, MDS, CTCL and FL.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SLAM BioTherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for SLAM BioTherapeutics's next move

See what Strategic adds

SLAM BioTherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.